These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results. Roehl KA, Eggener SE, Loeb S, Smith ND, Antenor JA, Catalona WJ. Urol Oncol; 2006 Nov; 24(6):465-71. PubMed ID: 17138126 [Abstract] [Full Text] [Related]
6. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy. Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML. J Urol; 2007 Oct; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121 [Abstract] [Full Text] [Related]
7. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer. Sengupta S, Blute ML, Bagniewski SM, Inman B, Leibovich BC, Slezak JM, Myers RP, Zincke H. BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824 [Abstract] [Full Text] [Related]
8. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume. Whitman EJ, Groskopf J, Ali A, Chen Y, Blase A, Furusato B, Petrovics G, Ibrahim M, Elsamanoudi S, Cullen J, Sesterhenn IA, Brassell S, Rittenhouse H, Srivastava S, McLeod DG. J Urol; 2008 Nov; 180(5):1975-8; discussion 1978-9. PubMed ID: 18801539 [Abstract] [Full Text] [Related]
10. Treatment delay and prognosis in invasive bladder cancer. Liedberg F, Anderson H, Månsson W. J Urol; 2005 Nov; 174(5):1777-81; discussion 1781. PubMed ID: 16217282 [Abstract] [Full Text] [Related]
11. Does initial surveillance in early prostate cancer reduce the chance of cure by radical prostatectomy?--A case control study. Khatami A, Damber JE, Lodding P, Pihl CG, Hugosson J. Scand J Urol Nephrol; 2003 Nov; 37(3):213-7. PubMed ID: 12775279 [Abstract] [Full Text] [Related]
12. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts. Malaeb BS, Rashid HH, Lotan Y, Khoddami SM, Shariat SF, Sagalowsky AI, McConnell JD, Roehrborn CG, Koeneman KS. Urol Oncol; 2007 Nov; 25(4):291-7. PubMed ID: 17628294 [Abstract] [Full Text] [Related]
17. Percentage of cancer in prostate biopsies as prognostic factor for staging and postoperative biochemical failure after radical prostatectomy. Villamón-Fort R, Martínez-Jabaloyas JM, Soriano-Sarriá P, Ramos-Soler D, Pastor-Hernández F, Gil-Salom M. Urol Int; 2007 Nov; 78(4):328-33. PubMed ID: 17495491 [Abstract] [Full Text] [Related]
18. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy. Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC, Epstein JI, Trock BJ, Gonzalgo ML. J Urol; 2007 Oct; 178(4 Pt 1):1311-5. PubMed ID: 17698095 [Abstract] [Full Text] [Related]
19. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients. May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O. J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719 [Abstract] [Full Text] [Related]